APTV · 8-K · 20260804PR000057
Guidance / Outlook
Aptiv PLC · 2026-08-04 · Importance 75 · Surprise 60 · Contradicted
Aptiv forecast third-quarter 2026 net sales of $3.120 billion to $3.220 billion and adjusted EBITDA of $545 million to $575 million, implying a 17.7% adjusted EBITDA margin at the midpoint. Full-year 2026 net sales guidance was $12.600 billion to $12.800 billion, with adjusted EBITDA of $2.310 billion to $2.370 billion and an 18.4% margin. Full-year free cash flow guidance was $625 million to $725 million, with capital expenditures expected to be approximately $600 million at the midpoint.
Key facts
- Q3 2026 net sales guidance (New Aptiv Pro Forma): $3,120 - $3,220 million; Full Year 2026 net sales guidance: $12,600 - $12,800 million. source
- Q3 2026 U.S. GAAP net income from continuing operations guidance: $180 - $200 million; Full Year 2026 guidance: $860 - $900 million. source
- Q3 2026 Adjusted EBITDA guidance: $545 - $575 million (Adjusted EBITDA margin 17.7%); Full Year 2026 Adjusted EBITDA guidance: $2,310 - $2,370 million (Adjusted EBITDA margin 18.4%). source
- Q3 2026 Cash flow from continuing operations guidance: $1,270 - $1,370 million; Full Year 2026 Free cash flow guidance: $625 - $725 million. source
- Pro forma Full Year 2026 Adjusted net income per share (New Aptiv Pro Forma) estimated at $5.70; diluted net income per share estimated at $4.16 (based on weighted average diluted shares of 211.50 million). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +329.7% | Q3 2026 net sales guidance (New Aptiv Pro Forma): $3,120 - $3,220 million; Full Year 2026 net sales guidance: $12,600 - $12,800 million. |
| revenue | positive | committed | +82.3% | Q3 2026 net sales guidance (New Aptiv Pro Forma): $3,120 - $3,220 million; Full Year 2026 net sales guidance: $12,600 - $12,800 million. |
| operating_income | positive | committed | +60.8% | Q3 2026 Adjusted EBITDA guidance: $545 - $575 million (Adjusted EBITDA margin 17.7%); Full Year 2026 Adjusted EBITDA guidance: $2,310 -… |
| net_income | positive | committed | +31.3% | Pro forma Full Year 2026 Adjusted net income per share (New Aptiv Pro Forma) estimated at $5.70; diluted net income per share estimated at… |
| net_income | positive | committed | +22.8% | Pro forma Full Year 2026 Adjusted net income per share (New Aptiv Pro Forma) estimated at $5.70; diluted net income per share estimated at… |
| operating_income | positive | committed | +14.5% | Q3 2026 Adjusted EBITDA guidance: $545 - $575 million (Adjusted EBITDA margin 17.7%); Full Year 2026 Adjusted EBITDA guidance: $2,310 -… |
| cash | positive | committed | +6.2% | Q3 2026 Cash flow from continuing operations guidance: $1,270 - $1,370 million; Full Year 2026 Free cash flow guidance: $625 - $725 million. |
| net_income | positive | committed | +4.9% | Q3 2026 U.S. GAAP net income from continuing operations guidance: $180 - $200 million; Full Year 2026 guidance: $860 - $900 million. |
| cash | positive | committed | +3.2% | Q3 2026 Cash flow from continuing operations guidance: $1,270 - $1,370 million; Full Year 2026 Free cash flow guidance: $625 - $725 million. |